WebAug 5, 2024 · Having grown by 60% since the end of FY 2024 (FY ends in May), Oracle’s stock (NYSE: ORCL) seems to be overvalued. ORCL’s stock grew from $51 at the end of FY 2024 to $81 now, compared to... WebApr 13, 2024 · The stock is rated as a Hold by 16 analyst(s), 13 recommend it as a Buy and 1 called the ORCL stock Overweight. In the meantime, 2 analyst(s) believe the stock as Underweight and 1 think it is a Sell. ... there are 2.70 billion shares outstanding. Nearly 42.60% of Oracle Corporation’s shares belong to company insiders and institutional ...
Oracle Corporation (ORCL) Stock Price & News - Google …
WebShares Outstanding Interactive chart of historical stock value for Oracle over the last 10 years. The value of a company is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Oracle market value as of March 22, 2024 is $234.77B. Compare ORCL With Other Stocks From: To: WebApr 11, 2024 · Oracle provides database technology and enterprise resource planning, or ERP, software to enterprises around the world. Founded in 1977, Oracle pioneered the first commercial SQL-based relational ... how is histology different from cytology
Oracle Sells $15 Billion of Debt, Drawing Two Credit Rating Cuts
WebAbout Real-Time Quotes. Nasdaq provides NLS Volume, Previous Close, Today's High & Low, and the 52 week High & Low. The intraday chart, the last-five real-time quotes and sales … WebOracle (ORCL) Stock Sinks As Market Gains: What You Should Know. In the latest trading session, Oracle (ORCL) closed at $87.96, marking a -0.79% move from the previous day. This change lagged the ... WebOracle Corp. U.S.: NYSE before hours $ 93.76 ORCL 0.00 0.00% Apr 11, 2024 4:56 a.m. EDT Before Hours Vol. 102 Price at close $ 93.76 -1.76 -1.84% Apr 10, 2024 4:03 p.m. EDT About Oracle Corp.... how is histolytica disease acquired